We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma

This study is currently recruiting participants.
Verified April 2017 by Rgenix, Inc.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02922764
First Posted: October 4, 2016
Last Update Posted: October 4, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Rgenix, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)